Farletuzumab ecteribulin, CAS [[2407465-18-1]]

Product Overview

• Article Name: Farletuzumab ecteribulin, CAS [[2407465-18-1]]
• Biozol Catalog Number: MCE-HY-P99612
• Supplier Catalog Number: HY-P99612
• Alternative Catalog Number: MCE-HY-P99612-1MG,MCE-HY-P99612-5MG,MCE-HY-P99612-10MG
• Manufacturer: MedchemExpress
• Category: Biochemikalien
• Alternative Names: MORAb-202

Product Description

Farletuzumab ecteribulin (MORAb-202) is an antibody-drug conjugate (ADC), consisting of the humanized anti-human folate receptor alpha (FRA) antibody Farletuzumab (HY-P99153) conjugated via reduced interchain disulfide bonds to Mal-PEG2-Val-Cit-PAB-eribulin. Farletuzumab ecteribulin has a agent-to-antibody ratio of 4.0. Farletuzumab ecteribulin is highly cytotoxic to FRA-positive cells in vitro. Farletuzumab ecteribulin has potent antitumor activity.

Product Properties

• Molecular Weight: 149000 (average)
• Purity: 99.40
• CAS Number: [2407465-18-1]
• Target: Antibody-Drug Conjugates (ADCs)

Application Notes

• Application Notes: MCE Product type: ADC Related